Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
6.91
+0.10 (1.40%)
Apr 1, 2026, 11:30 AM EDT - Market open
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $74.22 million as of April 1, 2026. Its market cap has increased by 4.77% in one year.
Market Cap
74.22M
Enterprise Value
-70.59M
1-Year Change
4.77%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $74.22M, a decrease of -75.40%. That is a compound annual growth rate of -22.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 73.20M | -13.98% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 76.48M |
| Rani Therapeutics Holdings | 73.28M |
| Fractyl Health | 72.63M |
| Cingulate | 72.21M |
| XBiotech | 71.95M |
| Grace Therapeutics | 71.64M |
| BeyondSpring | 70.73M |
| Pelthos Therapeutics | 70.50M |